LPS and LAM activation of the U373 astrocytoma cell line: Differential requirement for CD14

被引:13
作者
Orr, SL [1 ]
Tobias, P [1 ]
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF ENDOTOXIN RESEARCH | 2000年 / 6卷 / 03期
关键词
D O I
10.1177/09680519000060030201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD14 is a membrane protein (mCD14) found on monocytes and neutrophils that is required for the innate immune response to lipopolysaccharide (LPS) and lipoarabinomannan (LAM). CD14 can also be found in serum as soluble CD14 (sCD14) that when bound to bacterial products, enables many non-CD14 bearing cells to be activated. Lipopolysaccharide binding protein (LBP) is a plasma protein that disaggregates and catalytically transfers LPS to CD14. To examine the role of CD14 and LBP in LAM-dependent activation, we used the U373 astrocyte cell line to stably express membrane-bound CD14 (U373-CD14). In serum-free conditions, U373-CD14 cells could respond to LAM stimulation as measured by expression of intracellular adhesion molecule-1 (ICAM-1), Vector control cells (U373-RSV) could not respond to LAM or LPS; but, upon the addition of serum as a source of soluble CD14, control U373-RSV cells could respond to LPS, but not LAM. Therefore, LAM can activate U373 cells only through membrane CD14 and not soluble CD14. We also demonstrate that this membrane CD14-dependent LAM response is greatly facilitated by the addition of LBP.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 36 条
  • [1] BARNES PF, 1992, J IMMUNOL, V149, P541
  • [2] Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: Role of CD14 and the mannose receptor
    Bernardo, J
    Billingslea, AM
    Blumenthal, RL
    Seetoo, KF
    Simons, ER
    Fenton, MJ
    [J]. INFECTION AND IMMUNITY, 1998, 66 (01) : 28 - 35
  • [3] Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14:: Implications for myeloid and nonmyeloid cell activation
    Cunningham, MD
    Bajorath, J
    Somerville, JE
    Darveau, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) : 497 - 504
  • [4] Macrophage receptors for Mycobacterium tuberculosis
    Ernst, JD
    [J]. INFECTION AND IMMUNITY, 1998, 66 (04) : 1277 - 1281
  • [5] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
    FLYNN, JL
    GOLDSTEIN, MM
    CHAN, J
    TRIEBOLD, KJ
    PFEFFER, K
    LOWENSTEIN, CJ
    SCHREIBER, R
    MAK, TW
    BLOOM, BR
    [J]. IMMUNITY, 1995, 2 (06) : 561 - 572
  • [6] SOLUBLE CD14 PARTICIPATES IN THE RESPONSE OF CELLS TO LIPOPOLYSACCHARIDE
    FREY, EA
    MILLER, DS
    JAHR, TG
    SUNDAN, A
    BAZIL, V
    ESPEVIK, T
    FINLAY, BB
    WRIGHT, SD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1665 - 1671
  • [7] GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055
  • [8] Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14
    Haziot, A
    Katz, I
    Rong, GW
    Lin, XY
    Silver, J
    Goyert, SM
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (03) : 242 - 245
  • [9] HAZIOT A, 1993, J IMMUNOL, V151, P1500
  • [10] Hirschfeld M, 1999, J IMMUNOL, V163, P2382